Status:
COMPLETED
Safety and Efficacy of Cryoballoon Ablation of Atrial Fibrillation as First-line Therapy
Lead Sponsor:
Yuksek Ihtisas Hospital
Conditions:
Paroxysmal Atrial Fibrillation
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Cryoballoon ablation of paroxysmal atrial fibrillation can be used as first-line therapy compared to second choice after failed medical therapy
Eligibility Criteria
Inclusion
- paroxysmal atrial fibrillation, symptomatic
Exclusion
- atrial fibrillation other than PAF, asymptomatic, previous AF ablation
Key Trial Info
Start Date :
January 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2013
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01920295
Start Date
January 1 2011
End Date
April 1 2013
Last Update
August 9 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yuksek Ihtisas Heart-Education and Research Hospital
Ankara, Turkey (Türkiye), 06100